top of page


UK MHRA launches 2030 strategy to modernise AI, medical device and personalised medicine regulation
The UK's Medicines and Healthcare products Regulatory Agency has launched its 2030 strategy to modernise regulation of AI-enabled healthcare, medical devices and personalised medicines.

nuaxia
Oct 162 min read


UK government accepts all 44 recommendations for new healthcare AI regulatory framework
The UK government has accepted all 44 recommendations from the National Commission into the Regulation of AI in Healthcare, moving its proposed framework into implementation.

nuaxia
Oct 72 min read


Scotland backs UCB's Zilbrysq while NICE appraisal in England remains unresolved
The differing reimbursement positions highlight how health technology assessment decisions can diverge across UK nations, affecting the timing of patient access to new medicines.

nuaxia
Aug 132 min read


UK Biotech Financing Hits Five-Year High as Venture Capital Momentum Accelerates
Strong private investment signals renewed confidence in the UK life sciences sector, but public markets remain a challenge.

nuaxia
Jul 203 min read


UK Expands Wegovy Approval to Include MASH Treatment
The MHRA has conditionally approved Novo Nordisk’s GLP-1 therapy for adults with metabolic-associated steatohepatitis, marking another milestone in the evolution of obesity medicines.

nuaxia
Jul 73 min read


UK Biobank Data Incident Raises Critical Questions on Governance of De-Identified Patient Records
Listing of anonymised health data for 500,000 participants highlights growing tension between data access, global research collaboration, and patient trust.

nuaxia
Apr 243 min read
bottom of page